Matthew Pine

1.3k citations
7 papers · 1k · 2 hit papers · h-index 7

Impact in

  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • Immune responses and vaccinations
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • Immunotherapy and Immune Responses 3
    • Influenza Virus Research Studies 2
    • Respiratory viral infections research 1

Matthew Pine

7 papers receiving 985 citations

Matthew Pine's Hit Papers

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses 2021 · 592 citations
5920+2+4Years since publication100200300400500

Peers

Matthew Pine
Comparison fields: 5 of 64
  • Immunology 276
  • Infectious Diseases 219
  • Molecular Biology 383
  • Virology 23
  • Epidemiology 154
Replace Elinor Willis with:
Elinor Willis United States
Julia Z. Adamska United States
Katlyn Lederer United States
Tomaz B. Manzoni United States
Timothy A. Herring United States
Branka Grubor‐Bauk Australia
Takahiro Sanada Japan
Jenna L Lobby United States
Gustaf Lindgren Sweden
Minh Nguyet Pham United States
Matthew Pine relative to Elinor Willis United States Elinor Willis's profile →
Citations per field
00.5×1.5×2×2.4×
Elinor Willis · 1×
Citations per year

Countries citing papers authored by Matthew Pine

Since Specialization
Citations

This map shows the geographic impact of Matthew Pine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Pine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Pine more than expected).

Fields of papers citing papers by Matthew Pine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Pine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Pine. The network helps show where Matthew Pine may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Pine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Pine Line = papers co-authored together Matthew Pine links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Hit paper breakdown →
2021592
2
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Hit paper breakdown →
2020252
3 202361
4 202255
5 202132
6 201819
7 201811

About Matthew Pine

Matthew Pine is a scholar working on Immunology, Epidemiology, Parasitology, Urology and Molecular Biology, having authored 7 papers that have together received 1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Influenza Virus Research Studies (2 papers), RNA Interference and Gene Delivery (2 papers), Periodontal Regeneration and Treatments (1 paper), Vector-borne infectious diseases (1 paper), Tissue Engineering and Regenerative Medicine (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Immunology (276 citations), Infectious Diseases (219 citations), Molecular Biology (383 citations), Virology (23 citations) and Epidemiology (154 citations). Matthew Pine has collaborated with scholars based in United States, Brazil and Thailand. Frequent co-authors include Norbert Pardi, Ying K. Tam, Drew Weissman, Raffael Nachbagauer, Alec W. Freyn, Victoria C. Rosado, Florian Krammer, Peter Palese, Thomas D. Madden and Lynda Coughlan. Their work appears in journals such as Molecular Therapy, Immunity, Molecular Therapy — Methods & Clinical Development, Vaccine and Journal of Biomedical Materials Research Part B Applied Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact